Navigating the life science and healthcare funding landscape
Which capital funding options fit your healthcare or life science business?
Covid-19 was a lightning rod for life science deals last year. What investment trends are taking shape in 2021?
Peter Meath, Co-Head of Healthcare and Life Sciences for Middle Market Commercial Banking at J.P. Morgan, is bullish that the momentum will continue, particularly with investment trends focused on pain points amplified by the Covid-19 pandemic, from diagnostics development to supply chain management.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
J.P. Morgan’s life sciences outlook for 2021
Peter Meath, J.P. Morgan Commercial Banking’s Co-Head of Healthcare and Life Sciences, applies lessons from 2020’s remarkable second half and shares insights on what to expect in 2021.
Amazon-Berkshire-JPM venture recruits health insurance executive
Dana Gelb Safran, a Blue Cross Blue Shield of Massachusetts executive who works on analytics and improving outcomes, will serve as the initiative's "head of measurement," according to CNBC.
There’s now a COO for the Amazon-Berkshire-JPM initiative
The yet-unnamed Amazon-Berkshire Hathaway-J.P. Morgan healthcare venture has selected Jack Stoddard, who previously was Comcast's general manager of digital health, as its chief operating officer.
What Atul Gawande will bring to the table as CEO of Amazon-Berkshire-JPM venture
Effective July 9, surgeon and author Atul Gawande, who has been outspoken about healthcare costs and quality, will take over as CEO of the new initiative.
presented by
A Personalized Approach to Medication Nonadherence
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.
Amazon-JPM-Berkshire Hathaway healthcare initiative is having a tough time finding a CEO
According to a CNBC report, the three companies have shifted to looking for a candidate with a bit more entrepreneurial experience.
7 insider tricks GE Ventures uses to scale its portfolio companies
Only one in 500 new businesses in the United States will reach at least $100 million in revenue, and only one in 17,000 will see $500 million in revenue.
A start-up CEO’s takeaways from JP Morgan and the year ahead in digital health
Perspectives at this year's JP Morgan Healthcare Conference were telling about the state of digital health and prospects for 2016.
Is it warranted to be pessimistic about the current state of digital health?
As Lisa Suennen said about this year's JP Morgan Healthcare Conference, "There was a lot of optimism about the convergence of biotech, life sciences and health IT, but also there was a sense of foreboding that the party is over in some of these areas."
Maximize Revenue and Patient Care with Strategic Weight Loss Management
We will highlight Build My Health's revenue practice management tools, which could help physician practices add up to $250,000 to their practices.